Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

ExpreS2ion Biotechnologies - Rights Issue

By Michael FriisHead of Equities
31.03.2023, 13.00
ExpreS2ion Biotech Holding

ExpreS2ion Biotechnologies is currently carrying out a rights issue with preferential rights for existing shareholders. If fully subscribed, the rights issue will raise about SEK 102m in cash before costs in the first round, with the potential for an equal amount through a warrant program. Around 50% of the right issue is covered.

In a virtual live event today with CEO Bent Frandsen, we went through details and the plan of the rights issue, among others the use of the proceeds, and the options you have as an investor with preferential rights.

For further information, the prospectus can be found here: https://investor.expres2ionbio.com/wp-content/uploads/2023/03/2023-Rights-Issue-Prospectus-ENG.pdf

HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 17:00, 31 March 2023.

Recent videos

To
TORM – Præsentation af regnskabet for 2. kvartal 2025
14.08.2025, 16.00 Torm
Ca
CapMan Q2’25: Interesting times ahead
14.08.2025, 15.39 CapMan
SG
Sitowise Q2’25: Looking for clearer signs of recovery
14.08.2025, 15.29 Sitowise Group
Im
Implantica, Audiocast, Q2'25
14.08.2025, 15.00 Implantica
Ma
Marimekko, Webcast, Q2'25
14.08.2025, 13.00 Marimekko
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.